Mehabe score: 7 G Factor: 6 Piotski Score: 8 The stock has a rating . The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 6 and Piotski score of 8.
Description
Panama Petrochem is engaged in the manufacture of specialty petroleum products for diverse user industries like printing, textiles, rubber, pharmaceuticals, cosmetics, power and other industrial oil.(Source : 201903 Annual Report Page No: 89)Site:PANAMAPETMain Symbol:PANAMAPET
Stock trades at 267.0, above its 50dma 264.56. It also trades above its 200dma 203.48. The stock remains bullish on techicals
The 52 week high is at 309.80 and the 52week low is at 50.20
Price Chart
P/E Chart
Sales and Margin
Strengths
– has reduced debt.
– is almost debt free.
– is expected to give good quarter
– has delivered good profit growth of 43.59% CAGR over last 5 years
– has been maintaining a healthy dividend payout of 22.91%
Weakness
–
Competition
– The industry trades at a mean P/E of 6.9x. DCW trades at the industry’s max P/E of 31.31x. PANAMAPET trades at a P/E of 8.12x
– Industry’s mean G-Factor is 6.8 while the mean Piotski score is 9.0. PANAMAPET has a G-Factor of 6 and Piotski scoreof 8.
– Average 1 month return for industry is -9.0%. The max 1- month return was given by Manali Petrochem: a return of -0.6 %
Quarterly Results
Sales for period ended Sep 2021 is Rs 424.0 cr compared to Rs 280.0 cr for period ended Sep 2020, a rise of 51.4%
Operating Profits reported at Rs 67.0 cr for period ended Sep 2021 vis-vis 24.0 for period ended Sep 2020 .
Operating Margins expanded 723.0 bps for period ended Sep 2021 vis-vis Sep 2020 .
The EPS for Sep 2021 was Rs 8.12 compared to Rs 7.64 for previous quarter ended Jun 2021 and Rs 2.75 for Sep 2020
Profit & Loss Statement
Profit&Loss Comments
Company reported sales of Rs 1647.0 cr for period ended TTM vis-vis sales of Rs 1202.0 cr for the period ended Mar 2021, a healthy growth of 27.0%. The 3 year sales cagr stood at 15.2%.
Operating margins expanded to 17.0% for period ended TTM vis-vis 14.0% for period ended Mar 2021, expansion of 300.0 bps.
Net Profit reported at Rs 200.0 cr for period ended TTM vis-vis sales of Rs 123.0 cr for the period ended Mar 2021, rising 38.5%.
Company recorded a healthy Net Profit CAGR of 73.9% over the last 3 years
Balance Sheet Statement
Cash Flow Statement
Cash Flow comments
CashFlow from operating activities was positive.
Sales Growth
Profit Growth Statement
Profit Growth Statement
Stock Price CAGR
Return of Equity
General Comments
– The company has improved its Return on Equity (RoE) metric. The RoE on Last Year basis was 28.0% compared to 15.0% over the last 3 Years. – The stock has given a return of 307% on a 1 Year basis vis-vis a return of 25% over the last 3 Years. – The compounded sales growth on a TTM bassis is 112% vis-vis a compounded sales growth of 1% over the last 3 Years. – The compounded profit growth on a TTM basis is 695% vis-vis a compounded profit growth of 31% over the last 3 Years.
Ratios
Shareholding Pattern
– FII shareholding has remained largely constant. The Sep 2021 fii holding stood at 3.35% vis-vis 2.24% for Jun 2021 – Public shareholding has remained largely constant. The Sep 2021 public holding stood at 24.5% vis-vis 25.79% for Jun 2021
Conclusion
– has reduced debt.
– is almost debt free.
– is expected to give good quarter
– has delivered good profit growth of 43.59% CAGR over last 5 years
– has been maintaining a healthy dividend payout of 22.91% –
